Consolidated Portfolio Review Corp Nutri Band Inc. Put Options Transaction History
Consolidated Portfolio Review Corp
- $796 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NTRB
# of Institutions
23Shares Held
351KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA203KShares$1.12 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA59.9KShares$329,6860.0% of portfolio
-
State Street Corp Boston, MA25KShares$137,3130.0% of portfolio
-
Ubs Group Ag19.6KShares$108,0030.0% of portfolio
-
Cetera Investment Advisers Schaumburg, IL18.9KShares$103,9500.0% of portfolio
About NutriBand Inc.
- Ticker NTRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,803,260
- Market Cap $42.9M
- Description
- Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...